News Daily News CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally Michael O'Riordan December 14, 2022
News Daily News Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements Michael O'Riordan December 07, 2022
News Daily News A Simple Nudge Moves the Needle on Statin Prescribing Michael O'Riordan December 02, 2022
News Daily News Many ESC Guideline Recommendations Out of Reach in Poorer Regions Michael O'Riordan November 29, 2022
News Daily News Age-Related Macular Degeneration Linked to Severe Vascular Disease Caitlin E. Cox November 18, 2022
News Conference News AHA 2022 Common ‘Heart’ Supplements Can’t Beat Statins: SPORT Michael O'Riordan November 06, 2022
News Daily News Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events Yael L. Maxwell October 24, 2022
News Daily News Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive Michael O'Riordan September 09, 2022
News Conference News ESC 2022 Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration Michael O'Riordan August 29, 2022
News Conference News ESC 2022 Polypill Bests Usual Care in Patients With Recent MI: SECURE Michael O'Riordan August 26, 2022
News Features Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD? Michael O'Riordan August 15, 2022
News Daily News Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution Michael O'Riordan August 11, 2022
News Daily News CV Risk Factors, Disease Projected to Explode in Coming Decades L.A. McKeown August 01, 2022
News Daily News ‘Code Blue’ for the Dire CVD Health Status of Most US Adults Michael O'Riordan July 05, 2022
News Daily News Too Much Sitting Linked to Bad Outcomes Around the Globe: PURE Michael O'Riordan June 17, 2022
News Daily News Omega-3 Fatty Acids Linked to BP Reductions, Meta-analysis Hints L.A. McKeown June 06, 2022
News Conference News EAS 2022 Most Kids With FH Diagnosed by Cascade Screening, Albeit Late and Ineffectively Michael O'Riordan May 27, 2022
News Conference News EAS 2022 ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering Michael O'Riordan May 24, 2022
News Conference News EAS 2022 Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering Michael O'Riordan May 24, 2022
News Daily News Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV Michael O'Riordan May 09, 2022